An Duy Nguyen, MD

Dr. Nguyen’s research interests include breast cancer and colorectal cancer. He served as Principal Investigator on a double-blind, randomized phase 2b study of Sorafenib compared to placebo when administered in combination with chemotherapy for patients with locally advanced or metastatic breast cancer that have progressed during or after bevacizumab therapy.

Dr. Nguyen earned his medical degree from Albany Medical College. He then went on to complete his Hematology/Oncology Fellowship at Cedars-Sinai Olive View- UCLA Medical Centers. Dr. Nguyen is board certified in Oncology, Hematology and Internal Medicine.

• University of California, Irvine: Alpha Epsilon Delta Medical Honor Society, 1992
   – 1994

• A class of deep intronic IGHMBP2 variants activate a shared cryptic splice donor, enabling correction of select variants with a single antisense oligonucleotide. medRxiv. 2026 Apr 29.. View in PubMed